First study of the safety and tolerability of Allvec-1, a gene therapy vector, in patients with advanced stage IV malignant solid tumors
Reports of Radiotherapy and Oncology. 2015; 2 (1): 1-6
in En
| IMEMR
| ID: emr-175161
Responsible library:
EMRO
Search on Google
Index:
IMEMR
Main subject:
Carcinoma
/
Response Evaluation Criteria in Solid Tumors
/
Genetic Vectors
Limits:
Adult
/
Humans
/
Male
Language:
En
Journal:
Rep. Radiother. Oncol.
Year:
2015